FDA Proposes to Ease Rules for Pharmaceutical Ads on Social Media | Pharmaceutical Advertising | Legal & Regulatory Issues | Leadership | ANA

FDA Proposes to Ease Rules for Pharmaceutical Ads on Social Media

Recently, the Food and Drug Administration issued a draft guidance that proposes to make advertising prescription products on social media less burdensome. Comments are due on the FDA’s draft guidance within ninety days.